Myopia and Presbyopia Treatment Market Size & Growth Forecast 2027–2036, By Segments (Myopia Treatment Type, Presbyopia Treatment Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Myopia and Presbyopia Treatment Market size stood at USD 23.7 billion in 2026 and is predicted to grow at a 9.22% CAGR from 2027 to 2036, attaining USD 57.25 billion by 2036. The industry revenue for 2027 is assessed at USD 25.54 billion.
Get more details on this report
Request Free Sample ReportMyopia and Presbyopia Treatment Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific held the largest share in 2026, driven by a large patient base and sustained demand for corrective and therapeutic vision care solutions.
- North America is projected to grow at a 10.17% CAGR, supported by strong treatment adoption, established eye care infrastructure, and faster uptake of newer therapies.
Segment Momentum
- Corrective treatment held a 39.54% share in 2026 because it remains the most widely adopted first-line approach, supported by non-invasive vision correction, broad patient familiarity, and straightforward integration into routine eye care.
- Intraocular Lenses are the fastest-growing presbyopia treatment segment as patients increasingly seek longer-lasting vision correction options that reduce reliance on prescription eyewear and support greater convenience.
Market Expansion Drivers
- Rapid increase in global myopia prevalence driven by digital device overuse and urban lifestyles.
- Aging global population accelerating presbyopia-related vision correction demand.
- Advancements in pharmacological eye drops and specialty lenses improving non-invasive vision correction adoption.
Leading Market Participants
- Major players in the myopia and presbyopia treatment market include Alcon Inc. (Switzerland), Johnson & Johnson Vision Care, Inc. (United States), EssilorLuxottica S.A. (France), Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), NIDEK Co., Ltd. (Japan), Bausch + Lomb Corporation (Canada), Ziemer Ophthalmic Systems AG (Switzerland), Haag-Streit Holding AG (Switzerland), CooperVision, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 23.7 billion
- 2027 Estimated Market Size: USD 25.54 billion.
- Projected Market Size: USD 57.25 billion by 2036
- Growth Forecast: 9.22% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Asia Pacific
- High-Growth Regional Hub: North America
- Core Revenue Segment: Corrective (Myopia Treatment Type) | Prescription Lenses (Presbyopia Treatment Type)
- Emerging Opportunity Segment: Surgical (Myopia Treatment Type) | Intraocular Lenses (Presbyopia Treatment Type)
Market Growth Drivers and Industry Trends
Rapid increase in global myopia prevalence driven by digital device overuse and urban lifestyles
Rising exposure to digital devices and lifestyle patterns associated with urban environments is contributing to increasing myopia prevalence, expanding the population requiring vision correction and management. The myopia and presbyopia treatment market will see greater demand as more individuals require interventions to address progressive or persistent refractive errors. Increased reliance on near-vision activities and prolonged screen use is also strengthening awareness of vision-related concerns, encouraging individuals to seek assessment and treatment options such as corrective lenses and other available therapies.
Aging global population accelerating presbyopia-related vision correction demand
Demographic aging is expanding the number of individuals experiencing age-related difficulty with near vision, creating sustained demand for appropriate correction. As presbyopia becomes increasingly prevalent among older populations, the myopia and presbyopia treatment market is supported by greater need for solutions that restore functional near vision while accommodating patients' broader visual requirements. The growing importance of maintaining independence and everyday visual performance among aging individuals is encouraging greater use of corrective approaches suited to changing vision needs.
Advancements in pharmacological eye drops and specialty lenses improving non-invasive vision correction adoption
Innovation in pharmacological treatments and specialty lens technologies is expanding non-surgical approaches for managing refractive vision conditions. Advancements will support the myopia and presbyopia treatment market by giving patients access to alternatives that can address vision correction needs without relying exclusively on conventional surgical procedures. Improved treatment flexibility and the development of solutions tailored to specific visual conditions can increase patient acceptance of non-invasive options, particularly among individuals seeking approaches that can be incorporated into routine vision care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rapid increase in global myopia prevalence driven by digital device overuse and urban lifestyles | 2.30% | Moderate | Asia Pacific, North America | High | Mid Term |
| Aging global population accelerating presbyopia-related vision correction demand | 2.00% | Moderate | North America, Europe, Asia Pacific | High | Long Term |
| Advancements in pharmacological eye drops and specialty lenses improving non-invasive vision correction adoption | 1.60% | High | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Asia Pacific (Largest Region)
Asia Pacific led the myopia and presbyopia treatment market with the largest share in 2026, driven by a substantial need for vision correction across diverse and increasingly urbanized populations. Rising awareness of eye health, expanding access to ophthalmic care, and improvements in diagnostic capabilities are supporting treatment uptake across the region. Increasing demand for corrective solutions that address age-related and refractive vision problems is also strengthening the market, while healthcare infrastructure development is improving access to specialized eye-care services.
North America (Fastest-Growing Region)
North America is the fastest-growing regional market, supported by strong adoption of advanced vision-correction technologies, well-developed ophthalmic care infrastructure, and increasing consumer awareness of available treatment options. Greater access to specialized eye-care professionals facilitates diagnosis and personalized treatment, while technological progress is broadening the range of solutions available for managing myopia and presbyopia. Demand is further supported by a growing preference for effective and convenient approaches to long-term vision correction.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Treatment StandardsGermany emphasizes evidence-based ophthalmic care, encouraging adoption of advanced therapies and precision diagnostic technologies. Eye care providers in Germany prioritize clinically validated treatment options that improve long-term management of myopia and presbyopia.
France 🇫🇷
Integrated Ophthalmic CareFrance supports the myopia and presbyopia treatment market through established ophthalmology services and increasing adoption of advanced corrective technologies. Healthcare professionals in France focus on individualized treatment strategies that improve visual outcomes across different age groups.
Italy 🇮🇹
Specialist Eye ServicesItaly continues strengthening access to specialized ophthalmic treatments through expanding clinical capabilities and greater awareness of age-related vision disorders. Eye care providers in Italy increasingly adopt modern corrective procedures and advanced optical solutions for patient management.
Japan 🇯🇵
Aging Vision SolutionsJapan's aging population supports sustained demand for presbyopia management alongside increasing attention to myopia control among younger patients. Healthcare providers in Japan continue integrating advanced lenses, pharmaceuticals, and surgical solutions into routine eye care.
South Korea 🇰🇷
Preventive Eye ManagementSouth Korea places growing emphasis on early myopia management supported by advanced ophthalmic clinics and digital diagnostic technologies. Eye care providers in South Korea increasingly combine preventive approaches with modern vision correction options for long-term patient care.
United States 🇺🇸
Advanced Vision CareThe U.S. myopia and presbyopia treatment market benefits from broad adoption of innovative corrective procedures, premium ophthalmic products, and specialized eye care services. Healthcare providers across the U.S. continue expanding personalized treatment pathways for diverse patient populations.
Segment Leadership and Growth Trends
Myopia and Presbyopia Treatment Market Share (%), by Myopia Treatment Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMyopia Treatment Type Segment Analysis: Corrective (Largest Segment) vs Surgical (Fastest-Growing Segment)
Corrective treatments led the myopia and presbyopia treatment market in the myopia treatment type segment in 2026, holding a 39.54% share. Their leading position reflects the widespread need for non-surgical approaches to improve visual acuity among individuals with myopia. Corrective options such as prescription-based vision correction are accessible and can be adjusted as visual requirements change, making them suitable for broad patient populations. Growing awareness of vision health, increasing myopia prevalence, and continued demand for convenient methods of correcting refractive errors are supporting the established role of corrective treatments.
Surgical treatments represent the fastest-growing myopia treatment type, supported by increasing interest in procedures that can provide longer-term correction of refractive errors. Advances in ophthalmic technologies and surgical techniques are improving treatment precision and expanding the range of patients who may consider procedural correction. Greater awareness of available surgical alternatives, combined with patient interest in reducing reliance on conventional corrective methods, is contributing to stronger adoption of myopia surgery and supporting its accelerating role within the treatment landscape.
Presbyopia Treatment Type Segment Analysis: Prescription Lenses (Largest Segment) vs Intraocular Lenses (Fastest-Growing Segment)
Prescription lenses accounted for the largest share of the presbyopia treatment type segment in 2026, representing 31.97% share. Their established position is driven by their accessibility, adaptability, and suitability for individuals seeking non-invasive correction of age-related difficulty in near vision. Prescription lenses can be customized to individual visual requirements and incorporated into everyday routines, making them a practical option for a broad patient base. Increasing awareness of age-related vision changes and the continuing preference for established, adjustable corrective solutions support sustained demand for prescription lenses.
Intraocular lenses are the fastest-growing treatment type, reflecting increasing interest in procedural approaches that address presbyopia through replacement or modification of the eye's natural lens. Improvements in ophthalmic procedures and lens technologies are supporting greater consideration of these solutions among patients seeking alternatives to external corrective devices. The growing emphasis on personalized vision correction and longer-term treatment outcomes is encouraging adoption of intraocular lenses, strengthening their position within the evolving presbyopia treatment landscape.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Myopia Treatment Type | Corrective, Surgical, Drugs | Corrective | Surgical |
| Presbyopia Treatment Type | Prescription Lenses, Contact Lenses, Intraocular Lenses, Refractive Surgery | Prescription Lenses | Intraocular Lenses |
Competitive Landscape and Market Positioning
Prominent players in the myopia and presbyopia treatment market:
1. Alcon Inc. (Switzerland)
2. Johnson & Johnson Vision Care Inc. (United States)
3. EssilorLuxottica S.A. (France)
4. Carl Zeiss Meditec AG (Germany)
5. Topcon Corporation (Japan)
6. NIDEK Co. Ltd. (Japan)
7. Bausch + Lomb Corporation (Canada)
8. Ziemer Ophthalmic Systems AG (Switzerland)
9. Haag-Streit Holding AG (Switzerland)
10. CooperVision Inc. (United States)
The myopia and presbyopia treatment market is witnessing accelerated innovation supported by consolidation activities and the expansion of advanced vision correction portfolios. Development of next-generation lenses and minimally invasive corrective procedures is intensifying competition, while growing awareness of age-related vision disorders continues to drive market demand.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Alcon Inc. (Switzerland) | |||||||
| Johnson & Johnson Vision Care Inc. (United States) | |||||||
| EssilorLuxottica S.A. (France) | |||||||
| Carl Zeiss Meditec AG (Germany) | |||||||
| Topcon Corporation (Japan) | |||||||
| NIDEK Co. Ltd. (Japan) | |||||||
| Bausch + Lomb Corporation (Canada) | |||||||
| Ziemer Ophthalmic Systems AG (Switzerland) | |||||||
| Haag-Streit Holding AG (Switzerland) | |||||||
| CooperVision Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Tenpoint Therapeutics | Jan-26 | The FDA approved YUVEZZI (carbachol and brimonidine tartrate), a first-in-class dual-agent eye drop for presbyopia. The fixed-dose combination leverages a "pinhole effect" via pupillary constriction to improve near vision and depth of focus for up to 10 hours. This provides a non-invasive daily therapeutic option for adults, expanding the pharmacological management of age-related near vision loss. |
| Bruno Vision Care | Dec-25 | The FDA cleared Deseyne (vifilcon C) daily disposable contact lenses featuring Extended Depth of Focus (EDOF) technology. By utilizing a hyper-refractive central zone rather than traditional multifocal optics, the lenses provide continuous focus across near, intermediate, and distance ranges without the cognitive adaptation periods or visual distractions typically associated with multifocal contact lenses. |
| EssilorLuxottica | Sep-25 | The FDA approved Essilor Stellest spectacle lenses for the correction of myopia and the slowing of its progression in children. The lens utilizes advanced H.A.L.T. (Highly Aspherical Lenslet Target) technology to create a volume of myopic defocus, providing a non-invasive, clinically validated option to mitigate the progression of pediatric myopia. |
| Not Specified | Jul-25 | The FDA approved an aceclidine-based ophthalmic solution for the treatment of presbyopia. The once-daily, non-invasive eye drop enhances near vision by constricting the pupil, offering a targeted pharmacological approach to reduce reliance on reading glasses in adults by improving visual acuity for near-task performance over several hours. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Myopia and Presbyopia Treatment Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Pediatric, Adolescent & Young Adult, Middle-Aged Adults, Older Adults |
| Disease Severity | Mild, Moderate, Severe |
| Treatment Setting | Hospitals & Specialty Clinics, Ophthalmology Centers, Optometry Practices, Ambulatory Surgical Centers |
Myopia and Presbyopia Treatment Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Vision Correction Patient Journey Assessment |
|
| Refractive Care Delivery Ecosystem Analysis |
|
| Emerging Vision Care Business Models and Service Innovation |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of myopia and presbyopia treatment?
How much is the myopia and presbyopia treatment industry expected to grow by 2036?
How is earlier diagnosis of myopia influencing treatment adoption in the myopia and presbyopia treatment market?
Why are non-invasive treatment innovations gaining traction in the myopia and presbyopia treatment market?
Why is Corrective treatment the largest myopia treatment segment in the market?
Which presbyopia treatment type is growing the fastest in the market?
Why does Asia Pacific lead the myopia and presbyopia treatment market?
How is North America shaping future growth in myopia and presbyopia treatment?
Which companies dominate the myopia and presbyopia treatment landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization